Announcements Trials

Browse Landscape

Status

Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Pancreatic Neoplasms 4 Ovarian Neoplasms 2 Wilms Tumor 1 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Rare Diseases 1 Prostatic Neoplasms 1 Pancreatic Cyst 1 Neuroblastoma 1 Nervous System Neoplasms 1 Multiple Myeloma 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Intestinal Neuroendocrine Tumor 1 Frailty 1 Financial Stress 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Cognitive Dysfunction 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Brain Neoplasms 1 Bone Neoplasms 1

Interventions

Cyclophosphamide 28 fludarabine 19 Rituximab 17 obinutuzumab 12 venetoclax 10 Lenalidomide 9 Bendamustine Hydrochloride 9 Prednisone 7 zanubrutinib 6 Doxorubicin 6 Blood Specimen Collection 6 pembrolizumab 5 ibrutinib 5 fludarabine phosphate 5 Biopsy 5 glofitamab 4 Vincristine 4 Trimethoprim, Sulfamethoxazole Drug Combination 4 Exercise 4 loncastuximab tesirine 3 gamma-Globulins 3 axicabtagene ciloleucel 3 acalabrutinib 3 Temozolomide 3 Surveys and Questionnaires 3 Palliative Care 3 Mycophenolic Acid 3 Methotrexate 3 Mesna 3 Magnetic Resonance Spectroscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma × Data Collection × Clear all

NCT02869542 2016-08-17

Institut Paoli Calmettes Lymphoma Database

Institut Paoli-Calmettes

16,000 enrolled

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡